Kymera Therapeutics Presents Preclinical Data for KT-621, a Potent, Selective, First-In-Class, Oral STAT6 Degrader at the EADV Congress
September 25, 2024 07:00 ET
|
Kymera Therapeutics, Inc.
KT-621 has the potential to provide dupilumab-like activity with an oral small molecule profile for TH2 driven allergic and atopic disease KT-621 demonstrated strong degradation of STAT6 in human...
Steakholder Foods® Signs Commercial Sales Agreement for its Plant-Based Premixes with Bondor Foods
September 25, 2024 07:00 ET
|
STEAKHOLDER FOODS LTD.
Agreement Enables Bondor Foods to Launch Production of White Fish Kebab and Salmon Patties Developed Using Steakholder Foods’ Premixes, Marking Transition to Large-Scale Manufacturing Rehovot,...
Eightco Announces $100 million Revenue Forecast – Releases 2025 Strategic Plan
September 25, 2024 07:00 ET
|
Eightco Holdings Inc.
Improved Financial Condition Allows Focus on Revenue Growth & Profitability Easton, PA, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Eightco Holdings Inc. (NASDAQ: OCTO) (the “Company” or “Eightco”)...
Apellis Pharmaceuticals to Host a Fireside Chat at the UBS Virtual Ophthalmology Day
September 25, 2024 07:00 ET
|
Apellis Pharmaceuticals, Inc.
WALTHAM, Mass., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a fireside chat at the UBS Virtual Ophthalmology Day on...
Climb Channel Solutions Announces A-LIGN, Security and Compliance Partner, as Global Contract
September 25, 2024 07:00 ET
|
Climb Channel Solutions
EATONTOWN, N.J., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ:...
Johnson Outdoors Announces Cash Dividend
September 25, 2024 06:00 ET
|
Johnson Outdoors Inc.
RACINE, Wisc., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Johnson Outdoors Inc. (Nasdaq: JOUT), a leading global innovator of outdoor recreation equipment and technology, today announced approval by its...
ChampionX Publishes 2023 Sustainability Report
September 25, 2024 06:00 ET
|
ChampionX Corporation
ChampionX Corporation (Nasdaq: CHX) announces the release of its 2023 corporate sustainability report.
Alvotech hefur klíníska rannsókn á AVT16, fyrirhugaðri líftæknilyfjahliðstæðu við Entyvio
September 25, 2024 05:01 ET
|
Alvotech
Alvotech er einn tveggja aðila sem vitað er að hafi byrjað klíníska rannsókn á sjúklingum fyrir fyrirhugaða líftæknilyfjahliðstæðu við Entyvio (vedolizumab)Á síðustu tólf mánuðum, fram til loka...
Alvotech Initiates Confirmatory Patient Study for AVT16, a Proposed Biosimilar to Entyvio®
September 25, 2024 05:01 ET
|
Alvotech
Alvotech is one of two companies known to have initiated a global or multi-country confirmatory patient study for a biosimilar candidate to Entyvio®Sales of Entyvio (vedolizumab) were about $5.4...
Huize Holding Limited Reports Second Quarter 2024 Unaudited Financial Results
September 25, 2024 05:00 ET
|
Huize Holding Limited
SHENZHEN, China, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Huize Holding Limited, (“Huize”, the “Company” or “we”) (NASDAQ: HUIZ), a leading insurance technology platform connecting consumers, insurance...